TIDMPYC
RNS Number : 8595Q
Physiomics PLC
02 March 2021
2 March 2021
Physiomics plc
("Physiomics") or (the "Company")
Issue of Options
The Company considers that the award of options linked to the
Company's performance is critical to the incentivisation of its
directors and employees and to ensure that there is alignment
between management and shareholders. To this end, the Company today
confirms that it has agreed to issue share options (the "Options")
over ordinary shares of 0.4p each in the Company ("Ordinary
Shares") to its directors and employees, under the Company's
existing share option schemes (the "Schemes"), as detailed in this
announcement.
Each Option issued will be exercisable at a price of 7.55p,
being the greater of (i) the average closing price for the three
dealing days immediately preceding the date of grant; and (ii) the
closing price on the dealing day immediately prior to the date of
grant, as prescribed in the terms of the Schemes. The following
Options have been granted:
1. 985,454 Options to Dr James Millen under the Company's
Enterprise Management Initiative Employee Share Option Scheme;
2. 694,287 Options to Dr Christophe Chassagnole under the
Company's Enterprise Management Initiative Employee Share Option
Scheme;
3. 448,760 Options to Dr Paul Harper under the Company's
Non-Employee Share Option Scheme; and
4. 1,371,499 Options to other employees under the Company's
Enterprise Management Initiative Employee Share Option Scheme.
The Options vest equally over a three-year period and can be
exercised within 10 years of the date of grant.
Following this issue, the Directors will hold options over
Ordinary Shares in the Company in accordance with the table
below:
Option holder # Options Exercise price(p) Date of expiry
--------------------- --------------- ------------------ ---------------
P Harper 12,932 34.00 08-Nov-21
P Harper 51,752 13.20 11-Feb-23
P Harper 129,046 6.17 23-Mar-25
P Harper 258,092 3.50 20-Dec-25
P Harper 140,000 5.35 26-Mar-28
P Harper 448,760 7.55 02-Mar-31
Total P Harper 1,040,582
C Chassagnole 32,331 34.00 08-Nov-21
C Chassagnole 129,381 13.20 11-Feb-23
C Chassagnole 322,615 6.17 23-Mar-25
C Chassagnole 659,641 2.50 27-Feb-27
C Chassagnole 350,000 5.35 26-Mar-28
C Chassagnole 267,000 3.16 26-Mar-29
C Chassagnole 694,287 7.55 02-Mar-31
Total C Chassagnole 2,455,255
J Millen 520,000 5.35 26-Mar-28
J Millen 400,000 3.16 26-Mar-29
J Millen 985,454 7.55 02-Mar-31
Total J Millen 1,905,454
In addition, Dr Jim Millen owns 1,386,747 Ordinary Shares
(equivalent to approximately 1.42% of the currently issued share
capital), Dr Christophe Chassagnole owns 602,723 Ordinary Shares
(equivalent to approximately 0.62% of the currently issued share
capital) and Dr Paul Harper owns 668,564 Ordinary Shares
(equivalent to approximately 0.69% of the currently issued share
capital).
The total number of shares in issue remains 97,334,778 Ordinary
Shares with voting rights attached (one vote per Ordinary Share).
There are no Ordinary Shares held in treasury. This total voting
rights figure may be used by shareholders as the denominator for
the calculations by which they will determine whether they are
required to notify their interests in, or a change to their
interest in, Physiomics under the Disclosure and Transparency
Rules.
Enquiries:
Physiomics plc
Dr Jim Millen, CEO
+44 (0)1865 784 980
Strand Hanson Ltd (NOMAD)
James Dance & James Bellman
+44 (0) 20 7409 3494
Hybridan LLP (broker)
Claire Louise Noyce
+44 (0) 203 764 2341
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS
DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY
ASSOCIATED WITH THEM
1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Dr James Millen
--------------------------------------------------------------- ------------------------------
2 Reason for the notification
-----------------------------------------------------------------------------------------------
a) Position/status CEO
--------------------------------------------------------------- ------------------------------
b) Initial notification/ Amendment Initial
--------------------------------------------------------------- ------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
-----------------------------------------------------------------------------------------------
a) Name Physiomics PLC
--------------------------------------------------------------- ------------------------------
b) LEI 213800A71DSZ6ABMTQ91
--------------------------------------------------------------- ------------------------------
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
-----------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of instrument Options over Ordinary Shares
Identification code
GB00BDR6W943
--------------------------------------------------------------- ------------------------------
b) Nature of the transaction Issue of options
--------------------------------------------------------------- ------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
7.55 pence 985,454
----------
--------------------------------------------------------------- ------------------------------
d) Aggregated information
* Aggregated volume 985,454
7.55 pence
* Price
--------------------------------------------------------------- ------------------------------
e) Date of the transaction 2 March 2021
--------------------------------------------------------------- ------------------------------
f) Place of the transaction London, AIM
--------------------------------------------------------------- ------------------------------
1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Dr Christophe Chassagnole
--------------------------------------------------------------- ------------------------------
2 Reason for the notification
-----------------------------------------------------------------------------------------------
a) Position/status COO
--------------------------------------------------------------- ------------------------------
b) Initial notification/ Amendment Initial
--------------------------------------------------------------- ------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
-----------------------------------------------------------------------------------------------
a) Name Physiomics PLC
--------------------------------------------------------------- ------------------------------
b) LEI 213800A71DSZ6ABMTQ91
--------------------------------------------------------------- ------------------------------
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
-----------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of instrument Options over Ordinary Shares
Identification code
GB00BDR6W943
--------------------------------------------------------------- ------------------------------
b) Nature of the transaction Issue of options
--------------------------------------------------------------- ------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
7.55 pence 694,287
----------
--------------------------------------------------------------- ------------------------------
d) Aggregated information
* Aggregated volume 694,287
7.55 pence
* Price
--------------------------------------------------------------- ------------------------------
e) Date of the transaction 2 March 2021
--------------------------------------------------------------- ------------------------------
f) Place of the transaction London, AIM
--------------------------------------------------------------- ------------------------------
1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Dr Paul Harper
--------------------------------------------------------------- ------------------------------
2 Reason for the notification
-----------------------------------------------------------------------------------------------
a) Position/status Chairman
--------------------------------------------------------------- ------------------------------
b) Initial notification/ Amendment Initial
--------------------------------------------------------------- ------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
-----------------------------------------------------------------------------------------------
a) Name Physiomics PLC
--------------------------------------------------------------- ------------------------------
b) LEI 213800A71DSZ6ABMTQ91
--------------------------------------------------------------- ------------------------------
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
-----------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of instrument Options over Ordinary Shares
Identification code
GB00BDR6W943
--------------------------------------------------------------- ------------------------------
b) Nature of the transaction Issue of options
--------------------------------------------------------------- ------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
7.55 pence 448,760
----------
--------------------------------------------------------------- ------------------------------
d) Aggregated information
* Aggregated volume 448,760
7.55 pence
* Price
--------------------------------------------------------------- ------------------------------
e) Date of the transaction 2 March 2021
--------------------------------------------------------------- ------------------------------
f) Place of the transaction London, AIM
--------------------------------------------------------------- ------------------------------
The information contained within this announcement is deemed by
the Company to constitute inside information under the Market Abuse
Regulation (EU) No. 596/2014.
About Physiomics plc
Physiomics plc (AIM: PYC) is an oncology consultancy using
mathematical models to support the development of cancer treatment
regimens and personalised medicine solutions. The Company's Virtual
Tumour(TM) technology uses computer modelling to predict the
effects of cancer drugs and treatments to improve the success rate
of drug discovery and development projects while reducing time and
cost. The predictive capability of Physiomics' technologies have
been confirmed by over 80 projects, involving over 40 targets and
70 drugs, and has worked with clients such as Merck KGaA, Astellas,
Merck & Co and Bicycle Therapeutics.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHUURRRAKUORAR
(END) Dow Jones Newswires
March 02, 2021 05:12 ET (10:12 GMT)
Physiomics (LSE:PYC)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Physiomics (LSE:PYC)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
